• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型大肠杆菌天冬酰胺酶 II 突变体的分子动力学模拟和 QM-MM 研究降低急性淋巴细胞白血病的谷氨酰胺酶活性。

Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.

机构信息

Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Department of Biochemistry, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.

出版信息

Med Hypotheses. 2018 Mar;112:7-17. doi: 10.1016/j.mehy.2018.01.004. Epub 2018 Jan 30.

DOI:10.1016/j.mehy.2018.01.004
PMID:29447943
Abstract

L-Asparaginases (ASNase) belong to a family of amidohydrolases, have both asparaginase and glutaminase activity. Acute lymphocytic leukemia (ALL) is an outrageous disease worldwide. Bacterial ASNase has been used for the treatment of ALL. Glutaminase activity of enzyme causes some side effect and it is not essential for anticancer activity. The aim of this study was engineering of Escherichia coli asparaginase II to find a mutant with reduced glutaminase activity by molecular docking, molecular dynamics (MD) and QM-MM (Quantum mechanics molecular dynamics) simulations. Residues with low free energy of binding to Asn and high free binding energy to Gln were chosen for mutagenesis. Then, a mutant with higher glutaminase free binding energy was selected for further studies. Additionally, the MD simulation and QM-MM computation of wild type (WT) were employed and the selected mutated ASNase were analyzed and discussed. Our data showed that V27T is a good candidate to reduction the glutaminase activity, while has no remarkable effect on asparaginase activity of the enzyme. The simulation analysis revealed that V27T mutant is more stable than WT and mutant simulation was successful completely. QM-MM results confirmed the successfulness of our mutagenesis.

摘要

L-天冬酰胺酶(ASNase)属于酰胺水解酶家族,具有天冬酰胺酶和谷氨酰胺酶活性。急性淋巴细胞白血病(ALL)是一种全球性的恶性疾病。细菌 ASNase 已被用于 ALL 的治疗。酶的谷氨酰胺酶活性会引起一些副作用,并且对抗癌活性不是必需的。本研究的目的是通过分子对接、分子动力学(MD)和 QM-MM(量子力学分子动力学)模拟工程化大肠杆菌天冬酰胺酶 II,以找到一种突变体,其谷氨酰胺酶活性降低。选择与 Asn 结合自由能低、与 Gln 结合自由能高的残基进行突变。然后,选择具有更高谷氨酰胺酶自由结合能的突变体进行进一步研究。此外,还对野生型(WT)进行了 MD 模拟和 QM-MM 计算,并对选定的突变 ASNase 进行了分析和讨论。我们的数据表明,V27T 是降低谷氨酰胺酶活性的一个很好的候选者,同时对酶的天冬酰胺酶活性没有显著影响。模拟分析表明,V27T 突变体比 WT 更稳定,突变体模拟完全成功。QM-MM 结果证实了我们诱变的成功。

相似文献

1
Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.新型大肠杆菌天冬酰胺酶 II 突变体的分子动力学模拟和 QM-MM 研究降低急性淋巴细胞白血病的谷氨酰胺酶活性。
Med Hypotheses. 2018 Mar;112:7-17. doi: 10.1016/j.mehy.2018.01.004. Epub 2018 Jan 30.
2
Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).用于治疗急性淋巴细胞白血病的大肠杆菌天冬酰胺酶 II 的开发:通过新型突变体 (V27F) 降低天冬酰胺酶 II 的副作用的计算研究。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1137-1147. doi: 10.31557/APJCP.2021.22.4.1137.
3
Selective reduction in glutaminase activity of l‑Asparaginase by asparagine 248 to serine mutation: A combined computational and experimental effort in blood cancer treatment.通过 asparagine 248 到 serine 的突变选择性降低 l-天冬酰胺酶的谷氨酰胺酶活性:血液癌症治疗中的计算与实验综合研究。
Int J Biol Macromol. 2018 Dec;120(Pt B):2448-2457. doi: 10.1016/j.ijbiomac.2018.09.015. Epub 2018 Sep 4.
4
In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.对L-天冬酰胺酶进行计算机辅助工程改造,以降低谷氨酰胺酶的副活性,从而有效治疗急性淋巴细胞白血病。
J Pediatr Hematol Oncol. 2011 Dec;33(8):617-21. doi: 10.1097/MPH.0b013e31822aa4ec.
5
Rational engineering and insight for a L-glutaminase activity reduced type II L-asparaginase from Bacillus licheniformis and its antileukemic activity in vitro.理性工程设计降低地衣芽孢杆菌 II 型天冬酰胺酶的谷氨酸酶活性及其体外抗白血病活性。
Int J Biol Macromol. 2024 Feb;257(Pt 2):128690. doi: 10.1016/j.ijbiomac.2023.128690. Epub 2023 Dec 12.
6
A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.一种具有出色稳定性且在体外具有增强抗白血病活性的抗蛋白酶大肠杆菌天冬酰胺酶。
Sci Rep. 2017 Nov 3;7(1):14479. doi: 10.1038/s41598-017-15075-4.
7
The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.天冬酰胺酶的谷氨酰胺酶活性对于针对 ASNS 阴性细胞的抗癌活性并非必需。
Blood. 2014 Jun 5;123(23):3596-606. doi: 10.1182/blood-2013-10-535112. Epub 2014 Mar 21.
8
Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.改造大肠杆菌天冬酰胺酶的底物特异性。II. 通过248位氨基酸替换选择性降低谷氨酰胺酶活性
Protein Sci. 2000 Oct;9(10):2009-17. doi: 10.1110/ps.9.10.2009.
9
The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.天冬酰胺和谷氨酰胺促进封闭/活性酶构象的差异能力使沃林氏梭菌 L-天冬酰胺酶的底物特异性合理化。
Sci Rep. 2017 Jan 31;7:41643. doi: 10.1038/srep41643.
10
Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.L-天冬酰胺酶的谷氨酰胺酶活性有助于急性淋巴细胞白血病的持久临床前活性。
Mol Cancer Ther. 2019 Sep;18(9):1587-1592. doi: 10.1158/1535-7163.MCT-18-1329. Epub 2019 Jun 17.

引用本文的文献

1
Engineered L-asparaginase variants with enhanced therapeutic properties to improve treatment of childhood acute lymphatic leukemia.具有增强治疗特性的工程化L-天冬酰胺酶变体,用于改善儿童急性淋巴细胞白血病的治疗。
Cancer Gene Ther. 2025 Jul 30. doi: 10.1038/s41417-024-00865-6.
2
Unveiling the Catalytic Mechanism and Conformational Dynamics of Guinea Pig l‑Asparaginase Type 1 for Leukemia Drug Design.揭示用于白血病药物设计的豚鼠I型天冬酰胺酶的催化机制和构象动力学。
ACS Catal. 2025 Apr 29;15(10):7919-7933. doi: 10.1021/acscatal.4c07791. eCollection 2025 May 16.
3
Catechol-based chemistry for hypoglycemia-responsive delivery of zinc-glucagon via hydrogel-based microneedle patch technology.
基于儿茶酚化学的低血糖响应性锌-胰高血糖素递送,通过水凝胶基微针贴片技术实现。
Nat Commun. 2025 Apr 1;16(1):3124. doi: 10.1038/s41467-025-58278-4.
4
Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by Method Based on Sequence of the Enzyme from .基于来自[具体来源]的酶序列的方法设计的工程重组L-天冬酰胺酶的表达及生物学评价
Adv Pharm Bull. 2023 Nov;13(4):827-836. doi: 10.34172/apb.2023.085. Epub 2023 Jun 12.
5
Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.工程化与表达策略优化 L-天冬酰胺酶的开发与生产。
Int J Mol Sci. 2023 Oct 16;24(20):15220. doi: 10.3390/ijms242015220.
6
Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.酶工程策略用于增强作为生物制药的 L-天冬酰胺酶的生物利用度。
BioDrugs. 2023 Nov;37(6):793-811. doi: 10.1007/s40259-023-00622-5. Epub 2023 Sep 12.
7
Identification and Thermostability Modification of the Mesophilic L-asparaginase from Limosilactobacillus secaliphilus.嗜麦芽窄食单胞菌中嗜温L-天冬酰胺酶的鉴定及热稳定性修饰
Appl Biochem Biotechnol. 2024 Jun;196(6):3387-3401. doi: 10.1007/s12010-023-04715-3. Epub 2023 Sep 1.
8
Elucidation of the Active Form and Reaction Mechanism in Human Asparaginase Type III Using Multiscale Simulations.利用多尺度模拟阐明人源天冬酰胺酶 III 的活性形式和反应机制。
J Chem Inf Model. 2023 Sep 11;63(17):5676-5688. doi: 10.1021/acs.jcim.3c00900. Epub 2023 Aug 27.
9
Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems.用于提高异源系统中L-天冬酰胺酶表达的分子和代谢策略的当前状态。
Front Pharmacol. 2023 Jun 22;14:1208277. doi: 10.3389/fphar.2023.1208277. eCollection 2023.
10
Insights into the Distribution and Functional Properties of l-Asparaginase in the Archaeal Domain and Characterization of Asparaginase Belonging to the Novel Family Asp2like1.古菌域中天冬酰胺酶的分布与功能特性洞察以及属于新型Asp2like1家族的天冬酰胺酶的表征
ACS Omega. 2022 Nov 2;7(45):40750-40765. doi: 10.1021/acsomega.2c01127. eCollection 2022 Nov 15.